Compound names on this page link to vendor listings, not to
Retapedia articles. Retapedia earns a commission on purchases made
through them; see the affiliate
disclosure. Products are sold for laboratory research use and are not
approved for human consumption.
This page indexes every compound and blend catalogued on Retapedia together with the function each is researched for and its verdict under World Anti-Doping Agency rules. It repeats the list of peptides and the peptide stacks from the main page, with one difference: each compound name points at the vendor listing for that compound rather than at its article. The Article column keeps the encyclopedia entry one click away.
22 of 22 catalogued compounds currently have a listing. A compound with none renders as plain text.
Contents [hide]
Compounds
Ordered by current search popularity, most-searched first. Click a column header to re-sort.
| Compound⇵ | Function⇵ | Verdict⇵ | Article⇵ |
|---|---|---|---|
| NAD+ | Boosts cellular energy production and DNA repair. Activates longevity enzymes. Improves metabolism and mitochondrial health. Cellular benefits proven, human longevity unproven. | Natty | Read |
| Retatrutide | Triple agonist that curbs appetite and raises energy expenditure for 24% weight loss. Improves blood sugar, lowers blood pressure, and normalizes liver fat. Investigational; not FDA-approved. | Not natty | Read |
| Tirzepatide | Dual GIP/GLP-1 agonist. Reduces appetite for up to 21% weight loss. Improves blood sugar and diabetes control. First drug approved for obstructive sleep apnea. GI side effects common. | Natty | Read |
| Ozempic | Reduces appetite and slows digestion for 15-21% weight loss. Improves blood sugar control. Lowers heart attack and stroke risk by 20%. | Natty | Read |
| Glutathione | The body's master intracellular antioxidant. Scavenges free radicals and supports liver phase-II detoxification. Regenerates vitamins C and E. Used for liver health, skin brightening, and anti-aging. | Natty | Read |
| MOTS-c | Mitochondrial-derived peptide that activates AMPK to improve insulin sensitivity and reproduce exercise-like metabolic adaptations in preclinical models. Investigational and WADA-banned; no approved human use. | Not natty | Read |
| Tesamorelin | Stimulates growth hormone release, lowering visceral abdominal fat and triglycerides. FDA-approved for HIV-associated lipodystrophy. Daily subcutaneous injection; fat reaccumulates when stopped. | Not natty | Read |
| BPC-157 | Speeds healing of tendons, ligaments, muscles, and gut lining. Promotes new blood vessel growth and reduces inflammation. Evidence is almost entirely from animal studies. | Not natty | Read |
| Ipamorelin | Selectively triggers growth hormone release without raising cortisol or prolactin. Human efficacy unproven: a Phase 2 trial failed and body-composition benefits remain preclinical. Subcutaneous injection. | Not natty | Read |
| Semax | Synthetic ACTH(4-10) analogue used in Russia as a nootropic and neuroprotectant. Reported to raise BDNF without corticosteroid effects. Evidence is mostly preclinical; no FDA or EMA approval. | Not natty | Read |
| CJC-1295 | Raises growth hormone 2-10 fold and IGF-1 for over a week per injection. Weekly subcutaneous dosing. Investigational only; cardiovascular risks and product-quality concerns. | Not natty | Read |
| TB-500 | Speeds wound healing, muscle and tendon recovery. Reduces inflammation, improves joint mobility, minimizes scar tissue formation. | Not natty | Read |
| Copper peptide GHK-Cu | Copper-binding tripeptide that supports skin regeneration, collagen synthesis, wound healing, and hair growth, with antioxidant and anti-inflammatory activity. Used topically in cosmetics; deeper effects remain investigational. | Not natty | Read |
| Selank | Synthetic tuftsin analogue used as an anxiolytic nootropic. Reported to act on GABA and monoamine signalling without sedation or dependence. Registered as a medicine in Russia only. | Not natty | Read |
| Melanotan II | Stimulates melanin production to darken skin and facilitate tanning. May also increase sexual arousal and reduce appetite. Unapproved for human use; linked to nausea and mole changes. | Not natty | Read |
| Epithalon | Marketed as an anti-aging peptide. In preclinical studies it boosts telomerase activity, supports the body's own melatonin production, and shows antioxidant effects. Human evidence is minimal. | Not natty | Read |
| MK-677 | Oral ghrelin receptor agonist that raises growth hormone and IGF-1. Increases lean mass, bone density, and deep sleep. Causes insulin resistance and elevated blood sugar. | Not natty | Read |
| 5-Amino-1MQ | Oral small-molecule NNMT inhibitor that raises NAD+ and S-adenosyl methionine to boost fat-cell energy expenditure. Studied only in rodents for fat loss; no human trials exist. | Not natty | Read |
| IGF-1 LR3 | Long-acting IGF-1 analog studied preclinically for muscle growth and tissue repair. No peer-reviewed human evidence of benefit. Risks include hypoglycemia, joint pain, unproven cancer concerns. | Not natty | Read |
| Delta-sleep-inducing peptide | A neuropeptide named for inducing delta EEG sleep activity in animals, though its own link to human sleep is weak and poorly characterized. Shows preclinical antiepileptic activity. | Not natty | Read |
| Afamelanotide | Raises skin melanin by activating MC1 receptors. Approved to prevent phototoxic pain in erythropoietic protoporphyria, a rare genetic light sensitivity. Given as a subcutaneous implant. | Natty | Read |
| Bremelanotide | FDA-approved (as Vyleesi) for low sexual desire in premenopausal women. Activates central melanocortin receptors to drive arousal. Shows preclinical promise for erectile dysfunction. Given by subcutaneous injection. | Natty | Read |
Stacks
A stack is a fixed combination of two or more peptides sold in a single vial. A stack inherits the strictest verdict among its components: one compound marked "not natty" marks the whole vial.
| Stack⇵ | Function⇵ | Verdict⇵ | Contains⇵ |
|---|---|---|---|
| Wolverine | BPC-157 and TB-500 in one vial. Studied for angiogenesis, endothelial repair, and actin cytoskeletal remodeling in musculoskeletal recovery research. | Not natty | BPC-157 + TB-500 |
| GLOW | Adds GHK-Cu to the Wolverine pair. Studied for extracellular matrix remodeling and angiogenesis signaling. Common in dermal repair research. | Not natty | Copper peptide GHK-Cu + BPC-157 + TB-500 |
| KLOW | GLOW plus KPV. Studied for tissue repair signaling, inflammatory cytokine regulation, and extracellular matrix remodeling. | Not natty | KPV + Copper peptide GHK-Cu + BPC-157 + TB-500 |
Notes
- Verdicts come from each article's WADA status flag, so this page and the article always agree. See Natty status for the criteria.
- Retapedia does not manufacture, sell, or ship any compound, and does not endorse any vendor. See the medical disclaimer.
- A listing sells one presentation of a compound. An article's External links section lists every presentation available for that compound, including capsules, spray kits, and reconstitution supplies.